Developer docs
API playgroundTry for free, no card

Search company profiles

HORMOSAN

Full company profile

uuid002kz4w

Namestring
HORMOSAN
Legal namestring
Hormosan Pharma GmbH
Websiteurl
hormosan.com
Company typeenum
Private
Founded yearint
1975
Descriptiontext

HORMOSAN Pharma GmbH is a Frankfurt am Main-based German pharmaceutical company founded in 1975 and operating as a wholly-owned subsidiary of Lupin Limited, the Indian multinational pharmaceutical conglomerate. The company markets and distributes a diversified portfolio of innovative medications and generic pharmaceuticals across five therapeutic focus areas: rare neurological diseases (Myasthenia gravis, Myotonie, Chorea Huntington); pain therapy (migraine, cluster headache, general analgesics); sexual health (contraceptives, HIV/PrEP, erectile dysfunction, hair loss); respiratory diseases (asthma and COPD via inhalation therapy); and a broader generic portfolio. HORMOSAN positions itself as a specialist in underserved therapeutic niches rather than as a commodity generics supplier.

The company holds manufacturer authorization under §13 AMG and wholesale distribution permit under §52a AMG of the German Medicines Act, enabling in-country manufacturing authorization alongside distribution. It differentiates through specific formulations and dosage forms designed to improve patient compliance, supported by an extensive library of patient education materials, brochures, and adherence tools. The company maintains a medical-scientific hotline, customer service team, and HCP-targeted communications via DocCheck-secured professional content channels.

HORMOSAN operates a sales-led, B2B go-to-market model, distributing to pharmacies throughout Germany with a minimum order value of €150 and 30-day payment terms. Beyond its German commercial role, HORMOSAN functions as Lupin Limited's designated pharmacovigilance representative in the European Union, sharing data protection responsibilities with sister company Lupin Europe GmbH at the same Frankfurt address. The company employs 51-100 staff and is led by Managing Directors Thierry Volle, Sunil Makharia, and Peer Seeger.

Short descriptiontext

HORMOSAN Pharma GmbH is a Frankfurt-based, Lupin-owned German pharmaceutical company that markets and distributes innovative medications and generics across rare neurology, pain, sexual health, respiratory/inhalation, and general therapeutic areas, serving pharmacies throughout Germany.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersFrankfurt, Germany
HQ citystring
Frankfurt
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals, Rx medications, rare disease treatments, pain therapy drugs, sexual health pharmaceuticals
Industry4 codes
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAC
Neurology & CNS Specialty Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Products
TypeOne Time License
Description

Revenue generated from sale of innovative medications and generic pharmaceuticals across therapeutic areas including rare neurological diseases, pain therapy, sexual health, respiratory/inhalation, and general generics.

hormosan.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Minimum order value requirement
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Minimum order value of €150.00 per order. Prices in Euro, net, plus statutory VAT. Payment terms 30 days from invoice date.

hormosan.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

HORMOSAN Pharma GmbH is a German pharmaceutical company that manufactures and distributes prescription (Rx) medications, combining innovative drugs addressing unmet medical needs with a broad portfolio of high-quality generics. The company specializes in five therapeutic areas: rare neurological diseases (Myasthenia gravis, Myotonie, Chorea Huntington), pain therapy (migraine, cluster headache, analgesics), sexual health (contraceptives, HIV/PrEP, erectile dysfunction, hair loss), respiratory diseases (asthma/COPD inhalation therapy), and general generics, supported by patient education materials and accompanying services.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

HORMOSAN is a German pharmaceutical company offering a diversified portfolio of innovative medications and generic drugs for acute and chronic diseases. Their core offerings span five therapeutic focus areas: (1) Rare neurological diseases including Myasthenia gravis, myotonias, and Chorea Huntington, (2) Pain therapy including migraine and analgesics, (3) Sexual health covering contraceptives, HIV/PrEP, erectile dysfunction, and hair loss, (4) Respiratory diseases (asthma/COPD), and (5) A comprehensive generic portfolio. The company differentiates through specific formulations and delivery forms to improve patient compliance, combined with extensive patient education materials and support services.

Product and service1 record
1Seltene Erkrankungen in der Neurologie (Rare Neurological Disease Medications)
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

HORMOSAN is a subsidiary company (Ein Unternehmen der LUPIN Gruppe) of Lupin Limited, a major global pharmaceutical company headquartered in India. As part of the Lupin Group, HORMOSAN operates as the European subsidiary focusing on the German market, with joint data responsibility shared between Hormosan Pharma GmbH and Lupin Europe GmbH. Lupin Limited has designated HORMOSAN as its representative for pharmacovigilance activities in the European Union.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Laichingen-based German generics company specializing in cost-effective prescription medications distributed to pharmacies, closely matching HORMOSAN's generics positioning.

TypeDirect peer
Description

Germany's largest generics manufacturer (Sandoz/Novartis subsidiary) with broad portfolio including respiratory, neurology, and HIV products. Directly competes with HORMOSAN in German pharmacy generics and specialty categories.

TypeDirect peer
Description

German generics subsidiary of Teva Pharmaceutical Industries. Comparable to HORMOSAN as a mass-market German generics player with broad therapeutic coverage and pharmacy distribution.

TypeDirect peer
Description

Berlin-based German generics and specialty pharmaceutical company with portfolio spanning neurology, pain, respiratory, and other therapeutic areas, distributed through German pharmacies.

TypeDirect peer
Description

Augsburg-based German generics manufacturer with broad therapeutic portfolio distributed through German pharmacies, directly comparable to HORMOSAN's generics business.

TypeDirect peer
Description

German specialty pharma subsidiary within Dermapharm group focused on branded generics, neurology, and pain therapy products — comparable therapeutic mix and German pharmacy distribution model.

TypeDirect peer
Description

Major German generics and specialty pharmaceutical company headquartered in Bad Vilbel. Directly comparable as a mid-to-large German pharma player with a diversified generics and specialty portfolio across similar therapeutic areas, serving the same pharmacy distribution channel.

TypeDirect peer
Description

Nuremberg-based German generics manufacturer offering affordable alternatives across therapeutic categories, distributing through the same German pharmacy channel as HORMOSAN.

TypeDirect peer
Description

German mid-cap pharmaceutical company with focus on branded generics and specialty products including dermatology, neurology, and pain — operates a similar specialty/generics hybrid model.

TypeBroad incumbent
Description

German subsidiary of global biopharma major; while broader and more diversified, overlaps with HORMOSAN in neurology (e.g., central nervous system products) and operates in the same German Rx market.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HORMOSAN

Generic Pharmaceuticalshormosan.com

HORMOSAN Pharma GmbH is a Frankfurt-based, Lupin-owned German pharmaceutical company that markets and distributes innovative medications and generics across rare neurology, pain, sexual health, respiratory/inhalation, and general therapeutic areas, serving pharmacies throughout Germany.

What HORMOSAN does

HORMOSAN Pharma GmbH is a Frankfurt am Main-based German pharmaceutical company founded in 1975 and operating as a wholly-owned subsidiary of Lupin Limited, the Indian multinational pharmaceutical conglomerate. The company markets and distributes a diversified portfolio of innovative medications and generic pharmaceuticals across five therapeutic focus areas: rare neurological diseases (Myasthenia gravis, Myotonie, Chorea Huntington); pain therapy (migraine, cluster headache, general analgesics); sexual health (contraceptives, HIV/PrEP, erectile dysfunction, hair loss); respiratory diseases (asthma and COPD via inhalation therapy); and a broader generic portfolio. HORMOSAN positions itself as a specialist in underserved therapeutic niches rather than as a commodity generics supplier.

The company holds manufacturer authorization under §13 AMG and wholesale distribution permit under §52a AMG of the German Medicines Act, enabling in-country manufacturing authorization alongside distribution. It differentiates through specific formulations and dosage forms designed to improve patient compliance, supported by an extensive library of patient education materials, brochures, and adherence tools. The company maintains a medical-scientific hotline, customer service team, and HCP-targeted communications via DocCheck-secured professional content channels.

HORMOSAN operates a sales-led, B2B go-to-market model, distributing to pharmacies throughout Germany with a minimum order value of €150 and 30-day payment terms. Beyond its German commercial role, HORMOSAN functions as Lupin Limited's designated pharmacovigilance representative in the European Union, sharing data protection responsibilities with sister company Lupin Europe GmbH at the same Frankfurt address. The company employs 51-100 staff and is led by Managing Directors Thierry Volle, Sunil Makharia, and Peer Seeger.

HORMOSAN firmographics

Firmographics
Name
HORMOSAN
Legal name
Hormosan Pharma GmbH
Website
https://hormosan.com
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
51–100 employees
Short description
HORMOSAN Pharma GmbH is a Frankfurt-based, Lupin-owned German pharmaceutical company that markets and distributes innovative medications and generics across rare neurology, pain, sexual health, respiratory/inhalation, and general therapeutic areas, serving pharmacies throughout Germany.
Ownership category
akta.pro rank

HORMOSAN industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAH
Respiratory & Allergy Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIACAC
Neurology & CNS Specialty Pharmaceuticals
SECONDARYHLAIABAL
Generic Hospital & Institutional Products

Keywords

  • Generic pharmaceuticals
  • Rx medications
  • Rare disease treatments
  • Pain therapy drugs
  • Sexual health pharmaceuticals

Where HORMOSAN is headquartered

Location

Headquarters

HQ city
Frankfurt
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

HORMOSAN business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Products: Revenue generated from sale of innovative medications and generic pharmaceuticals across therapeutic areas including rare neurological diseases, pain therapy, sexual health, respiratory/inhalation, and general generics.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goMinimum order value requirement

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

HORMOSAN product offering

Product offering

Core offering

HORMOSAN Pharma GmbH is a German pharmaceutical company that manufactures and distributes prescription (Rx) medications, combining innovative drugs addressing unmet medical needs with a broad portfolio of high-quality generics. The company specializes in five therapeutic areas: rare neurological diseases (Myasthenia gravis, Myotonie, Chorea Huntington), pain therapy (migraine, cluster headache, analgesics), sexual health (contraceptives, HIV/PrEP, erectile dysfunction, hair loss), respiratory diseases (asthma/COPD inhalation therapy), and general generics, supported by patient education materials and accompanying services.

Product overview

HORMOSAN is a German pharmaceutical company offering a diversified portfolio of innovative medications and generic drugs for acute and chronic diseases. Their core offerings span five therapeutic focus areas: (1) Rare neurological diseases including Myasthenia gravis, myotonias, and Chorea Huntington, (2) Pain therapy including migraine and analgesics, (3) Sexual health covering contraceptives, HIV/PrEP, erectile dysfunction, and hair loss, (4) Respiratory diseases (asthma/COPD), and (5) A comprehensive generic portfolio. The company differentiates through specific formulations and delivery forms to improve patient compliance, combined with extensive patient education materials and support services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Seltene Erkrankungen in der Neurologie (Rare Neurological Disease Medications)

Companies that use HORMOSAN

Customer profile

Segments6 records

Ideal customer profiles2 records

HORMOSAN technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

HORMOSAN partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Lupin GroupcoreOthersHORMOSAN is a subsidiary company (Ein Unternehmen der LUPIN Gruppe) of Lupin Limited, a major global pharmaceutical company headquartered in India. As part of the Lupin Group, HORMOSAN operates as the European subsidiary focusing on the German market, with joint data responsibility shared between Hormosan Pharma GmbH and Lupin Europe GmbH. Lupin Limited has designated HORMOSAN as its representative for pharmacovigilance activities in the European Union.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

HORMOSAN competitors and assessment

Company assessment

Direct peers

  • ALIUD Pharma GmbH: Laichingen-based German generics company specializing in cost-effective prescription medications distributed to pharmacies, closely matching HORMOSAN's generics positioning.
  • Hexal AG: Germany's largest generics manufacturer (Sandoz/Novartis subsidiary) with broad portfolio including respiratory, neurology, and HIV products. Directly competes with HORMOSAN in German pharmacy generics and specialty categories.
  • ratiopharm GmbH (Teva): German generics subsidiary of Teva Pharmaceutical Industries. Comparable to HORMOSAN as a mass-market German generics player with broad therapeutic coverage and pharmacy distribution.
  • Aristo Pharma GmbH: Berlin-based German generics and specialty pharmaceutical company with portfolio spanning neurology, pain, respiratory, and other therapeutic areas, distributed through German pharmacies.
  • betapharm Arzneimittel GmbH: Augsburg-based German generics manufacturer with broad therapeutic portfolio distributed through German pharmacies, directly comparable to HORMOSAN's generics business.
  • Mibe GmbH Arzneimittel: German specialty pharma subsidiary within Dermapharm group focused on branded generics, neurology, and pain therapy products — comparable therapeutic mix and German pharmacy distribution model.
  • Stada Arzneimittel AG: Major German generics and specialty pharmaceutical company headquartered in Bad Vilbel. Directly comparable as a mid-to-large German pharma player with a diversified generics and specialty portfolio across similar therapeutic areas, serving the same pharmacy distribution channel.
  • Heumann Pharma GmbH & Co. Generica KG: Nuremberg-based German generics manufacturer offering affordable alternatives across therapeutic categories, distributing through the same German pharmacy channel as HORMOSAN.
  • Dermapharm Holding SE: German mid-cap pharmaceutical company with focus on branded generics and specialty products including dermatology, neurology, and pain — operates a similar specialty/generics hybrid model.

Broad incumbents

  • AbbVie Deutschland GmbH & Co. KG: German subsidiary of global biopharma major; while broader and more diversified, overlaps with HORMOSAN in neurology (e.g., central nervous system products) and operates in the same German Rx market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

HORMOSAN social profiles

Digital presence

HORMOSAN compliance and trust

Trust signal

Compliance1 record

HORMOSAN financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HORMOSAN leadership team

Management profile

Number of profiles

Profiles6 records

HORMOSAN funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HORMOSAN M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HORMOSAN

What does HORMOSAN do?

HORMOSAN Pharma GmbH is a German pharmaceutical company that manufactures and distributes prescription (Rx) medications, combining innovative drugs addressing unmet medical needs with a broad portfolio of high-quality generics. The company specializes in five therapeutic areas: rare neurological diseases (Myasthenia gravis, Myotonie, Chorea Huntington), pain therapy (migraine, cluster headache, analgesics), sexual health (contraceptives, HIV/PrEP, erectile dysfunction, hair loss), respiratory diseases (asthma/COPD inhalation therapy), and general generics, supported by patient education materials and accompanying services.

Is HORMOSAN a public or private company?

HORMOSAN is a private company. It is classified as corporate owned and is currently operating.

When was HORMOSAN founded?

HORMOSAN was founded in 1975. It employs 51 to 100 people.

Where is HORMOSAN based?

HORMOSAN is headquartered in Frankfurt, Germany, in the Europe region.

How does HORMOSAN make money?

One revenue line is on record: pharmaceutical Products.

Who are HORMOSAN's main competitors?

Direct peers on record are ALIUD Pharma GmbH, Hexal AG, ratiopharm GmbH (Teva), Aristo Pharma GmbH, betapharm Arzneimittel GmbH, Mibe GmbH Arzneimittel, Stada Arzneimittel AG, Heumann Pharma GmbH & Co. Generica KG and Dermapharm Holding SE. AbbVie Deutschland GmbH & Co. KG is listed as a broad incumbent.

Does HORMOSAN have an API?

No public API is recorded for HORMOSAN.

What industry is HORMOSAN in?

HORMOSAN's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAIAAAH, Respiratory & Allergy Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals